Peer-reviewed veterinary case report
Evaluation of the effects of a single bolus of cisatracurium as part of an anesthetic protocol in cats undergoing orthopedic surgery.
- Journal:
- BMC veterinary research
- Year:
- 2026
- Authors:
- Interlandi, Claudia et al.
- Affiliation:
- Department of Veterinary Sciences · Italy
- Species:
- cat
Abstract
Non-depolarizing neuromuscular blocking agents (NMBAs) are commonly used in human anesthesia but remain uncommon in veterinary medicine. This study evaluated the effects of 0.5 mg/kg cisatracurium IV on muscle relaxation, cardiovascular variables and postoperative pain in cats undergoing orthopedic surgery. Twenty-four cats were randomly assigned to a control group (Group C) or a treatment group receiving cisatracurium (Group M) immediately after induction. Neuromuscular function was monitored using a calibrated train-of-four (TOF) device. Postoperative pain was assessed with the short form of the Glasgow Feline Composite Measure Pain Scale (CMPS-Feline). The mean time to suppression of muscle contraction was 2.6 ± 0.8 min, with peak suppression (90%) at 3.0 ± 0.7 min, a mean duration of 23.3 ± 4.4 min, and complete recovery at 27.3 ± 8.6 min. Group M required lower sevoflurane concentrations to maintain anesthesia compared to Group C (p < 0.001) and had a shorter mean surgical time (25.3 ± 3 min vs. 31.5 ± 4 min; p < 0.001). Pain scores were also lower in Group M (p = 0.01). These findings demonstrate that cisatracurium effectively induces neuromuscular block (NMB) and improves surgical conditions, resulting in lower postoperative pain scores in cats undergoing femoral fracture repair.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/41917956/